These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23331007)

  • 21. Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation.
    Jin X; Jeon HY; Joo KM; Kim JK; Jin J; Kim SH; Kang BG; Beck S; Lee SJ; Kim JK; Park AK; Park WY; Choi YJ; Nam DH; Kim H
    Cancer Res; 2011 Apr; 71(8):3066-75. PubMed ID: 21363911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity.
    Gangemi RM; Griffero F; Marubbi D; Perera M; Capra MC; Malatesta P; Ravetti GL; Zona GL; Daga A; Corte G
    Stem Cells; 2009 Jan; 27(1):40-8. PubMed ID: 18948646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apoptosis-related gene expression in tumor tissue samples obtained from patients diagnosed with glioblastoma multiforme.
    Blahovcova E; Richterova R; Kolarovszki B; Dobrota D; Racay P; Hatok J
    Int J Mol Med; 2015 Dec; 36(6):1677-84. PubMed ID: 26459752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 17AEP-GA, an HSP90 antagonist, is a potent inhibitor of glioblastoma cell proliferation, survival, migration and invasion.
    Miekus K; Kijowski J; Sekuła M; Majka M
    Oncol Rep; 2012 Nov; 28(5):1903-9. PubMed ID: 22941268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Taking advantage of neural development to treat glioblastoma.
    Zhang Z; Lin CC
    Eur J Neurosci; 2014 Sep; 40(6):2859-66. PubMed ID: 24964151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of 2-oxindole based multi-targeted inhibitors of PDK1/Akt signaling pathway for the treatment of glioblastoma multiforme.
    Sestito S; Nesi G; Daniele S; Martelli A; Digiacomo M; Borghini A; Pietra D; Calderone V; Lapucci A; Falasca M; Parrella P; Notarangelo A; Breschi MC; Macchia M; Martini C; Rapposelli S
    Eur J Med Chem; 2015 Nov; 105():274-88. PubMed ID: 26498573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. z-Leucinyl-leucinyl-norleucinal induces apoptosis of human glioblastoma tumor-initiating cells by proteasome inhibition and mitotic arrest response.
    Monticone M; Biollo E; Fabiano A; Fabbi M; Daga A; Romeo F; Maffei M; Melotti A; Giaretti W; Corte G; Castagnola P
    Mol Cancer Res; 2009 Nov; 7(11):1822-34. PubMed ID: 19861404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The status of the art of human malignant glioma management: the promising role of targeting tumor-initiating cells.
    Florio T; Barbieri F
    Drug Discov Today; 2012 Oct; 17(19-20):1103-10. PubMed ID: 22704957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human tissue engineering allows the identification of active miRNA regulators of glioblastoma aggressiveness.
    Cosset E; Petty T; Dutoit V; Tirefort D; Otten-Hernandez P; Farinelli L; Dietrich PY; Preynat-Seauve O
    Biomaterials; 2016 Nov; 107():74-87. PubMed ID: 27614160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs as regulators of neural stem cell-related pathways in glioblastoma multiforme.
    González-Gómez P; Sánchez P; Mira H
    Mol Neurobiol; 2011 Dec; 44(3):235-49. PubMed ID: 21728042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNAs as Multifaceted Players in Glioblastoma Multiforme.
    Mercatelli N; Galardi S; Ciafrè SA
    Int Rev Cell Mol Biol; 2017; 333():269-323. PubMed ID: 28729027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy.
    Nikaki A; Piperi C; Papavassiliou AG
    Expert Opin Investig Drugs; 2012 Oct; 21(10):1475-88. PubMed ID: 22809292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-Mediated Dynamic Bidirectional Shift between the Subclasses of Glioblastoma Stem-like Cells.
    Rooj AK; Ricklefs F; Mineo M; Nakano I; Chiocca EA; Bronisz A; Godlewski J
    Cell Rep; 2017 Jun; 19(10):2026-2032. PubMed ID: 28591575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PKCδ maintains phenotypes of tumor initiating cells through cytokine-mediated autocrine loop with positive feedback.
    Kim RK; Suh Y; Hwang E; Yoo KC; Choi KS; An S; Hwang SG; Kim IG; Kim MJ; Lee HJ; Lee SJ
    Oncogene; 2015 Nov; 34(46):5749-59. PubMed ID: 25746003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA targeting as a therapeutic strategy against glioma.
    Auffinger B; Thaci B; Ahmed A; Ulasov I; Lesniak MS
    Curr Mol Med; 2013 May; 13(4):535-42. PubMed ID: 22934848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The MET oncogene in glioblastoma stem cells: implications as a diagnostic marker and a therapeutic target.
    Boccaccio C; Comoglio PM
    Cancer Res; 2013 Jun; 73(11):3193-9. PubMed ID: 23695554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-21: A key player in glioblastoma pathogenesis.
    Masoudi MS; Mehrabian E; Mirzaei H
    J Cell Biochem; 2018 Feb; 119(2):1285-1290. PubMed ID: 28727188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glioblastoma: exosome and microRNA as novel diagnosis biomarkers.
    Saadatpour L; Fadaee E; Fadaei S; Nassiri Mansour R; Mohammadi M; Mousavi SM; Goodarzi M; Verdi J; Mirzaei H
    Cancer Gene Ther; 2016 Dec; 23(12):415-418. PubMed ID: 27834360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting glioblastoma cancer stem cells: the next great hope?
    Khan IS; Ehtesham M
    Neurosurg Focus; 2014 Dec; 37(6):E7. PubMed ID: 25581936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNAs in glioblastoma: role in pathogenesis and opportunities for targeted therapies.
    Costa PM; Cardoso AL; Mano M; de Lima MC
    CNS Neurol Disord Drug Targets; 2015; 14(2):222-38. PubMed ID: 25613511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.